BJS Open最新文献

筛选
英文 中文
Disparities in pathways for anaemia care and recovery among women after major abdominal surgery: secondary analysis of a prospective cohort study in 29 countries. 腹部大手术后妇女贫血护理和康复途径的差异:对29个国家前瞻性队列研究的二次分析
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag125
Sivesh Kathir Kamarajah, Dharani Hapangama
{"title":"Disparities in pathways for anaemia care and recovery among women after major abdominal surgery: secondary analysis of a prospective cohort study in 29 countries.","authors":"Sivesh Kathir Kamarajah, Dharani Hapangama","doi":"10.1093/bjsopen/zrag125","DOIUrl":"10.1093/bjsopen/zrag125","url":null,"abstract":"<p><strong>Background: </strong>Anaemia is a common modifiable risk factor in surgery, yet how it is recognized and managed in women across different surgical pathways is unknown. This study aimed to evaluate anaemia prevalence in women and its management across surgical pathways and life stages, examine associations with 30-day outcomes, and estimate the potential benefit of anaemia correction.</p><p><strong>Methods: </strong>A secondary analysis was conducted of a prospective cohort study from 427 hospitals in 29 countries, including women having elective major abdominal surgery. The primary exposure was surgical pathway (gynaecology versus non-gynaecology), used as a pragmatic proxy for pathway design. Preoperative anaemia and perioperative iron therapy were conceptualized as mediators; menopausal status (pre- versus postmenopausal, by age) was a prespecified effect modifier. Coprimary outcomes were 30-day unplanned readmission and days alive and out of the hospital 30 days from surgery (DAOH30). Mixed-effects logistic regression was used with a hospital random intercept for readmission, and quantile regression for DAOH30. A 2000-iteration cluster bootstrap estimated absolute risk reduction and number needed to treat (NNT = 1/absolute risk difference) for counterfactual anaemia correction in key subgroups. Natural-effects models assessed whether recorded perioperative iron therapy partly explained the pathway differences in readmission.</p><p><strong>Results: </strong>A total of 10 114 women (median age 57.6 years (interquartile range 48.0-69.0)) were included; 3590 (35.5%) were premenopausal and 3214 (31.8%) underwent gynaecological surgery. Preoperative anaemia was present in 29.0% and was more frequent in non-gynaecology than gynaecology (31.9% versus 22.8%). Thirty-day unplanned readmission occurred in 7.2%. In adjusted models, the gynaecology pathway had lower odds of readmission than non-gynaecology (adjusted odds ratio 0.78, 95% confidence interval 0.62 to 0.97), whereas preoperative anaemia was associated with higher readmission (adjusted odds ratio 1.28, 1.06 to 1.56). Lower perioperative iron use in non-gynaecology partly mediated the pathway gap (indirect effect odds ratio 1.06, 1.02 to 1.09; proportion mediated 15.2%). The largest model-based absolute risk difference was observed among women of premenopausal age undergoing non-gynaecological surgery: predicted readmission was 11.8% with anaemia versus 6.4% without anaemia, corresponding to an absolute risk difference of 5.32% and an NNT estimand of 19. Median DAOH30 was 26 days (interquartile range 23-28). Anaemia was associated with fewer days at home, with the largest decrement among those with poorest recovery (10th percentile β -3.0 days, 95% confidence interval -4.0 to -2.0), a smaller reduction at the median (β -1.0 days, -1.3 to -0.72), and no difference at the 90th percentile.</p><p><strong>Conclusion: </strong>For women, pathway design, not only patient risk, shapes whethe","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149079566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for idiopathic granulomatous mastitis: scoping review. 特发性肉芽肿性乳腺炎的危险因素:范围审查。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag137
Rute S S Castelhano, Leah Argus, Daniel Ahari, Goonj Johri, Emma MacInnes, Shaneel Shah, Christopher Darlow, Vijay Sharma, Rudresh Shukla, Iain Lyburn, Nisha Sharma, Roisin Bradley, Cliona C Kirwan
{"title":"Risk factors for idiopathic granulomatous mastitis: scoping review.","authors":"Rute S S Castelhano, Leah Argus, Daniel Ahari, Goonj Johri, Emma MacInnes, Shaneel Shah, Christopher Darlow, Vijay Sharma, Rudresh Shukla, Iain Lyburn, Nisha Sharma, Roisin Bradley, Cliona C Kirwan","doi":"10.1093/bjsopen/zrag137","DOIUrl":"10.1093/bjsopen/zrag137","url":null,"abstract":"<p><strong>Background: </strong>Idiopathic granulomatous mastitis (IGM) is a rare, benign, inflammatory breast condition. The diagnostic challenge can cause delays in diagnosis and treatment. The quality of evidence for the diagnosis and management of IGM is low. A scoping review of existing literature was conducted to determine risk factors for IGM, with the aim of informing clinical suspicion, earlier diagnosis, and treatment of this condition.</p><p><strong>Methods: </strong>A scoping review of the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases (2003-2023) was performed following PRISMA-ScR guidance. Data on demographics, reproductive history, hormonal factors, body mass index (BMI), and smoking were extracted and subjectively compared to appropriate published population demographics of the relevant risk factors.</p><p><strong>Results: </strong>In all, 230 studies involving 13 062 patients were included. Most common countries of publication origin were Turkey (86 papers; 5233 patients), the USA (30 studies; 764 patients), and China (23 papers; 3990 patients), with three papers (25 patients) from the UK. Most common ethnicities reported were Hispanic (36%), Turkish (20%), White (9%), and Middle Eastern (8%). The mean age (34.7 years) was consistent across the literature, except for UK publications (mean age 50 years). High rates of history of pregnancy (> 90%) were reported, except for UK papers (68%); 64-85% of patients had a history of lactation; and the prevalence of hyperprolactinaemia (reported in 18% of papers) was 5% (versus 0.4% in the general population). BMI appears to match age and country-equivalent BMIs, with no association with diabetes. Smoking association is inconclusive.</p><p><strong>Conclusion: </strong>Risk factors for IGM appear centred on reproductive, hormonal, ethnicity, and possibly geographical factors, although the data are limited by inconsistent reporting, small study sizes, and retrospective study designs.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149079614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outpatient non-operative treatment of uncomplicated acute appendicitis: meta-analysis. 非并发症急性阑尾炎门诊非手术治疗:荟萃分析。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag138
Mauro Podda, Adolfo Pisanu, Fausto Catena, Marco Ceresoli
{"title":"Outpatient non-operative treatment of uncomplicated acute appendicitis: meta-analysis.","authors":"Mauro Podda, Adolfo Pisanu, Fausto Catena, Marco Ceresoli","doi":"10.1093/bjsopen/zrag138","DOIUrl":"10.1093/bjsopen/zrag138","url":null,"abstract":"","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13560070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148918348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International expert consensus on managing elective hernia repair in patients with Crohn's disease using the Delphi method. 国际专家对克罗恩病患者择期疝修补术采用德尔菲法的共识。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag172
Hans Lovén, Frederik Helgstrand, Hans Friis-Andersen, Conrad Ballecer, Frederik Berrevoet, Marja Boermeester, Hanna de la Croix, Christine Gaarder, Ismail Gögenur, Nadia Henriksen, William Hope, Kamal Itani, Lars N Jørgensen, Ferdinand Köckerling, Jan Roland Lambrecht, Marc Miserez, Ulf Petersson, Thomas Pinkney, Benjamin K Poulose, Michael Rosen, Jacob Rosenberg, David L Sanders, Dominic Slade, Björn Törnqvist, Thue Bisgaard
{"title":"International expert consensus on managing elective hernia repair in patients with Crohn's disease using the Delphi method.","authors":"Hans Lovén, Frederik Helgstrand, Hans Friis-Andersen, Conrad Ballecer, Frederik Berrevoet, Marja Boermeester, Hanna de la Croix, Christine Gaarder, Ismail Gögenur, Nadia Henriksen, William Hope, Kamal Itani, Lars N Jørgensen, Ferdinand Köckerling, Jan Roland Lambrecht, Marc Miserez, Ulf Petersson, Thomas Pinkney, Benjamin K Poulose, Michael Rosen, Jacob Rosenberg, David L Sanders, Dominic Slade, Björn Törnqvist, Thue Bisgaard","doi":"10.1093/bjsopen/zrag172","DOIUrl":"10.1093/bjsopen/zrag172","url":null,"abstract":"<p><strong>Background: </strong>Patients with Crohn's disease (CD) may be predisposed to mesh-related complications such as impaired wound healing and fistula formation following hernia repair. With limited evidence and no established guidelines for hernia repair in CD, this Delphi study aimed to establish a hernia expert consensus on elective inguinal, incisional, and parastomal hernia repair in patients with CD.</p><p><strong>Methods: </strong>A three-round Delphi process including 21 hernia experts from Europe and the USA was conducted between 24 April and 15 October 2025. The primary outcome of interest was a consensus ≥ 75% among participants. Near consensus was defined as ≥ 70% agreement. Statements were developed from participant comments and questionnaire responses. Experts evaluated statements on timing, surgical approach, and mesh selection (synthetic non-absorbable, synthetic absorbable, biosynthetic, biological, and non-mesh) across different CD subtypes in elective inguinal, incisional, and parastomal hernia repair. Patients were categorized into three CD subtypes, namely abdominal fistulizing Crohn's disease (FCD), isolated perianal FCD, and non-FCD, with each assessed in both active and non-active inflammatory disease states.</p><p><strong>Results: </strong>Consensus or near consensus was achieved for 12 of 20 items (60%) in Round 1, 17 of 33 items (52%) in Round 2, and 13 of 29 items (45%) in Round 3. Overall, 42 of 72 unique items reached consensus (34 items) or near consensus (8 items). It was suggested that elective hernia repair should be avoided in CD patients with active inflammation, regardless of abdominal FCD or non-FCD. In non-active CD, synthetic non-absorbable mesh was suggested for inguinal, incisional, and parastomal hernia repair. Standard mesh placement was recommended for inguinal hernias, whereas retromuscular or preperitoneal mesh placement was recommended for incisional and parastomal hernias. No consensus was reached to avoid elective repair in isolated perianal FCD with active inflammation. The use of non-mesh repair, synthetic absorbable, biological, or biosynthetic mesh was generally not recommended in the elective setting.</p><p><strong>Conclusions: </strong>Consensus was reached that CD with non-active inflammation does not require deviation from standard hernia repair principles provided that the mesh is positioned in extraperitoneal positions. However, patients with CD may have an increased perioperative risk and the surgical management should be guided by shared decision-making.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13675246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a population-based cohort of breast cancer patients. 在以人群为基础的乳腺癌患者队列中,保留乳头乳房切除术和基于植入物的即时乳房重建术后的长期肿瘤预后。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag114
Helena Sackey, Ira Oikonomou, Yihang Liu, Axel Frisell, Hannah Coudé Adam, Dhirar Ansarei, Martin Halle, Anna L V Johansson, Jana de Boniface
{"title":"Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a population-based cohort of breast cancer patients.","authors":"Helena Sackey, Ira Oikonomou, Yihang Liu, Axel Frisell, Hannah Coudé Adam, Dhirar Ansarei, Martin Halle, Anna L V Johansson, Jana de Boniface","doi":"10.1093/bjsopen/zrag114","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag114","url":null,"abstract":"<p><strong>Background: </strong>Nipple-sparing mastectomy (NSM) offers superior cosmetic and patient-reported outcomes compared with skin-sparing mastectomy (SSM), although its oncological safety remains debated. This study evaluated recurrence and survival after NSM versus SSM in women with breast cancer receiving implant-based immediate breast reconstruction (IBR).</p><p><strong>Methods: </strong>The population-based Stockholm Breast Reconstruction Database, including all women with breast cancer who underwent implant-based IBR in Stockholm from 2005 to 2015, was reviewed. Data were collected from medical chart review and the National Quality Register for Breast Cancer. The primary outcomes were long-term local recurrence (LR) rates and overall survival (OS) after NSM versus SSM. Survival probabilities and hazard ratios (HR) with their 95% confidence interval (c.i.) were estimated with a maximum 12 years of follow-up.</p><p><strong>Results: </strong>Of 1687 patients registered in the database, this analysis included 1594 implant-based IBRs performed in 1537 women with primary breast cancer. Of these, 86.3% (1376 breasts) had SSM and 13.7% had NSM (218 breasts). The median follow-up was 75 months for SSM and 60 months for NSM. The use of NSM increased from 7.6% in 2005-2007 to 26.6% in 2014-2015 (P < 0.001). LR occurred in 50 breasts, 13 after NSM and 37 after SSM, with a 12-year cumulative incidence of 14.1% for NSM and 3.7% for SSM (P = 0.001). Among the 13 LRs after NSM, 4 (30.8%) were localized in or beneath the nipple-areola complex. The unadjusted HR was 3.18 (95% c.i. 1.67 to 6.03) and remained significant in the multivariable analysis (HR 2.08; 95% c.i. 1.01 to 4.28). OS did not differ significantly (HR 0.74; 95% c.i. 0.38 to 1.44).</p><p><strong>Conclusion: </strong>NSM was associated with an increased risk of LR compared with SSM, whereas no significant association with OS was observed. Whether these results can be attributed to more residual breast glandular tissue needs to be evaluated in further research.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, practice, and barriers to opportunistic salpingectomy during non-gynaecological surgery: international survey. 非妇科手术中机会性输卵管切除术的知识、实践和障碍:国际调查。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag145
Jeremy Meyer, Manuela Undurraga, Frédéric Ris, Thibaud Koessler, Intidhar Labidi-Galy
{"title":"Knowledge, practice, and barriers to opportunistic salpingectomy during non-gynaecological surgery: international survey.","authors":"Jeremy Meyer, Manuela Undurraga, Frédéric Ris, Thibaud Koessler, Intidhar Labidi-Galy","doi":"10.1093/bjsopen/zrag145","DOIUrl":"10.1093/bjsopen/zrag145","url":null,"abstract":"","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smoking, obesity and reoperation after elective open mesh repair of umbilical hernia: nationwide cohort study. 吸烟、肥胖与脐疝择期开放式补片术后再手术:全国队列研究。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag136
Jeppe Fredberg, Erling Oma, Frederik Helgstrand, Lars N Jorgensen
{"title":"Smoking, obesity and reoperation after elective open mesh repair of umbilical hernia: nationwide cohort study.","authors":"Jeppe Fredberg, Erling Oma, Frederik Helgstrand, Lars N Jorgensen","doi":"10.1093/bjsopen/zrag136","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag136","url":null,"abstract":"<p><strong>Introduction: </strong>Evidence of the effects of obesity and smoking on complication-related reintervention after elective umbilical hernia mesh repair is limited. This study evaluated the association between these factors and reoperation after mesh repair.</p><p><strong>Methods: </strong>A nationwide cohort of elective open umbilical hernia repairs from 2017 to 2020 was identified from prospective registration in the Danish Hernia Database. Patients were followed until 31 December 2023 through nationwide registries and complete scrutiny of operative notes associated with succeeding reinterventions. Study outcomes were reoperation for any complication, recurrence, or non-recurrence complication with special reference to the repair method. Multivariable analyses included cause-specific hazard models with adjustment for body mass index (BMI), smoking status, sex, age, and hernia size.</p><p><strong>Results: </strong>Of the 2391 patients included in the study, 18.4% were smokers and 34.0% were obese (BMI > 30 kg/m2). The follow-up rate was 99.9% over a median of 4.65 years. Reoperation for any complication was increased in smokers compared with non-smokers (hazard ratio (HR) 1.68; 95% confidence interval (c.i.) 1.05 to 2.69; P = 0.032). Reoperation for non-recurrence complications was more frequent in smokers (HR 2.01; 95% c.i. 1.19 to 3.38; P = 0.009) and obese patients (HR 1.83; 95% c.i. 1.12 to 3.00; P = 0.016). Comparable risks of reoperation for hernia recurrence were found between smokers and non-smokers (HR 0.80; 95% c.i. 0.23 to 2.73; P = 0.721) and between patients with and without obesity (HR 0.73; 95% c.i. 0.26 to 2.09; P = 0.559).</p><p><strong>Conclusion: </strong>Reoperation for any complication after open umbilical hernia mesh repair was more frequent in smokers, whereas no independent association was observed between patients with and without obesity. Smoking and obesity were associated with an increased risk of reoperation for non-recurrence complications, while not affecting reoperation for hernia recurrence.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International expert consensus on perioperative management of carcinoid crisis. 类癌危象围手术期处理的国际专家共识。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag159
Julie Hallet, Fahad Alam, Stefano Partelli, Jonathan Koea, Flavio Rocha, Stephanie Ladowski, Jaydira Del Rivero, Chadi Saliba, Jessica Armah, Rodney Pommier
{"title":"International expert consensus on perioperative management of carcinoid crisis.","authors":"Julie Hallet, Fahad Alam, Stefano Partelli, Jonathan Koea, Flavio Rocha, Stephanie Ladowski, Jaydira Del Rivero, Chadi Saliba, Jessica Armah, Rodney Pommier","doi":"10.1093/bjsopen/zrag159","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag159","url":null,"abstract":"<p><strong>Background: </strong>Carcinoid crisis is a critical concern for patients with neuroendocrine tumours undergoing invasive procedures. Guidance is needed to standardize and optimize perioperative care for patients at risk of carcinoid crisis. Consensus-based expert recommendations were developed for the perioperative management of carcinoid crisis among patients with midgut and bronchopulmonary neuroendocrine tumours undergoing non-cardiac surgery.</p><p><strong>Methods: </strong>A modified Delphi approach was used with four rounds of voting to reach expert consensus on statements about perioperative management of carcinoid crisis. A multidisciplinary international panel of 44 experts was formed, and 3 patient partners were engaged. Statements addressing preoperative, intraoperative, and postoperative considerations were created. Panellists rated statements on a Likert scale (from 1 to 7). Three additional rounds of iterative rating and feedback were completed anonymously. Consensus was defined with median score between 5 and 7, and ≤ 13 panellists rating outside the score category containing the median.</p><p><strong>Results: </strong>Final consensus was reached on 41 statements. Of these, 12 focused on preoperative work-up and optimization, 27 on intraoperative management including monitoring, prophylaxis, and treatment of crisis, and 2 on postoperative management. The principal practice-shifting recommendations were that somatostatin analogues are not necessary for prophylaxis before surgery or on the day of operation, and treatment in the event of carcinoid crisis should start with vasopressors, with short-acting somatostatin analogues used as an adjunct.</p><p><strong>Conclusion: </strong>Using modified Delphi methodology, recommendations to guide the perioperative management of carcinoid crisis were developed. Considering the importance of carcinoid crisis on the management and outcomes of patients undergoing surgical resection for neuroendocrine tumours, this guidance can help standardize care and optimize outcomes.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries. 修正:评估选择性和紧急卫生系统中结直肠癌手术的质量:对95个国家前瞻性队列研究的二次分析。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag200
{"title":"Correction: Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries.","authors":"","doi":"10.1093/bjsopen/zrag200","DOIUrl":"10.1093/bjsopen/zrag200","url":null,"abstract":"","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13715442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study. 胰腺和壶腹周围癌(PANODE)胰十二指肠切除术中淋巴结站16b1、9和8a受损伤对生存率的影响:前瞻性多中心研究
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag157
J Annelie Suurmeijer, Bobby K Pranger, Leonard W F Seelen, Mahsoem Ali, L Bengt van Rijssen, Dorine S Tseng, Tara M Mackay, Jacob L van Dam, Hjalmar C van Santvoort, Bas Groot Koerkamp, Arantza Farina Sarasqueta, Casper H van Eijck, Mike S L Liem, Geert Kazemier, Vincent B Nieuwenhuijs, Ignace H de Hingh, Joost M Klaase, Joris I Erdmann, Olivier R Busch, I Quintus Molenaar, Vincent E de Meijer, Marc G Besselink
{"title":"Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study.","authors":"J Annelie Suurmeijer, Bobby K Pranger, Leonard W F Seelen, Mahsoem Ali, L Bengt van Rijssen, Dorine S Tseng, Tara M Mackay, Jacob L van Dam, Hjalmar C van Santvoort, Bas Groot Koerkamp, Arantza Farina Sarasqueta, Casper H van Eijck, Mike S L Liem, Geert Kazemier, Vincent B Nieuwenhuijs, Ignace H de Hingh, Joost M Klaase, Joris I Erdmann, Olivier R Busch, I Quintus Molenaar, Vincent E de Meijer, Marc G Besselink","doi":"10.1093/bjsopen/zrag157","DOIUrl":"10.1093/bjsopen/zrag157","url":null,"abstract":"<p><strong>Background: </strong>Current guidelines do not recommend routine sampling of lymph node stations (LNS) 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic ductal adenocarcinoma (PDAC) and other periampullary cancers because prospective multicentre studies are lacking. This study evaluated the association between the involvement of these LNS and overall survival (OS).</p><p><strong>Methods: </strong>This prospective multicentre study included patients undergoing pancreatoduodenectomy for PDAC, distal cholangiocarcinoma, ampullary cancer, or duodenal cancer between October 2015 and April 2020. Associations between involvement of LNS 16b1, 9, and 8a and OS were analysed using multivariable Cox regression analyses.</p><p><strong>Results: </strong>Among 1218 included patients, 673 had PDAC, 228 had distal cholangiocarcinoma, 212 had ampullary cancer, and 105 had duodenal cancer. LNS 16b1 involvement was associated with worse OS in PDAC (10 versus 24 months; adjusted hazard ratio (aHR) 2.33; 95% confidence interval (c.i.) 1.62 to 3.35), distal cholangiocarcinoma (7 versus 28 months; aHR 6.95; 95% c.i. 2.88 to 16.77), ampullary cancer (9 versus 62 months; aHR 4.35; 95% c.i. 1.73 to 10.94), and duodenal cancer (13 months versus endpoint not reached; aHR 3.95; 95% c.i. 1.15 to 13.47). LNS 8a involvement was associated with worse OS in PDAC (13 versus 22 months; aHR 1.38; 95% c.i. 1.03 to 1.86), distal cholangiocarcinoma (16 versus 26 months; aHR 1.68; 95% c.i. 1.00 to 2.81), and ampullary cancer (16 versus 62 months; aHR 2.89; 95% c.i. 1.51 to 5.53). LNS 9 involvement was associated with worse OS only in ampullary cancer (4 versus 35 months; aHR 8.19; 95% c.i. 2.34 to 28.57).</p><p><strong>Conclusion: </strong>LNS 16b1 involvement was associated with poor OS in PDAC and periampullary cancer. Future studies should assess routine preoperative and intraoperative sampling of LNS 16b1 and the impact of neoadjuvant treatment.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13686085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149236889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书